Back to Market Feed

Product Information

INVEGA SUSTENNA 117 MG/0.75 ML is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $2340.7788 per ML under NDC 50458056201. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Jul 31, 2009.

INVEGA SUSTENNA 117 MG/0.75 ML

paliperidone palmitate
$2340.7788per ML

Strength

117 mg/.75mL

NDC

50458056201

Classification

Brand

Dosage Form

INJECTION

Route

INTRAMUSCULAR

Effective Date

8/19/2026

Active Ingredients

PALIPERIDONE PALMITATE

Approval Type

New Drug (NDA)

FDA Application

NDA022264

FDA Approved

7/31/2009

On Market Since

7/31/2009

Pharmacological Classes

Atypical Antipsychotic

Price Statistics

The NADAC for INVEGA SUSTENNA 117 MG/0.75 ML has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 104.9%. The table below summarizes its recorded NADAC range and movement.

Current price$2340.7788 per ML
All-time high$2344.7659 (Jun 10, 2026)
All-time low$1142.5583 (Nov 28, 2013)
52-week high$2344.7659
52-week low$2282.5219
Median price$1797.5591
Average price$1773.6618
Largest weekly change+6.9% (Jan 16, 2019)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-0.1%

1M

-0.1%

3M

-0.2%

6M

+0.0%

1Y

+2.6%

3Y

+9.1%

5Y

+24.2%

All

+104.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the paliperidone palmitate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

SEROQUEL 25 MG TABLET
Brand
00310027510•AstraZeneca Pharmaceuticals LP
$3.7108
per EA
RISPERDAL 0.5 MG TABLET
Brand
50458030201•Janssen Pharmaceuticals Inc.
$4.3842
per EA
RISPERDAL 0.5 MG TABLET
Brand
50458030206•Janssen Pharmaceuticals Inc.
$4.3842
per EA
RISPERDAL 1 MG TABLET
Brand
50458030001•Janssen Pharmaceuticals Inc.
$4.6907
per EA
RISPERDAL 1 MG TABLET
Brand
50458030006•Janssen Pharmaceuticals Inc.
$4.6907
per EA
RISPERDAL 1 MG/ML SOLUTION
Brand
50458030503•Janssen Pharmaceuticals Inc.
$5.2820
per ML
SEROQUEL 50 MG TABLET
Brand
00310027810•AstraZeneca Pharmaceuticals LP
$6.0917
per EA
SEROQUEL 100 MG TABLET
Brand
00310027110•AstraZeneca Pharmaceuticals LP
$6.3807
per EA
CLOZARIL 25 MG TABLET
Brand
69809012605•HLS Therapeutics (USA), Inc.
$6.5446
per EA
SEROQUEL XR 50 MG TABLET
Brand
00310028060•AstraZeneca Pharmaceuticals LP
$7.7675
per EA

Frequently asked questions

What is the NADAC price of INVEGA SUSTENNA 117 MG/0.75 ML?

The current National Average Drug Acquisition Cost (NADAC) for INVEGA SUSTENNA 117 MG/0.75 ML, manufactured by Janssen Pharmaceuticals Inc., is $2340.7788 per ML (NDC 50458056201), effective Aug 19, 2026.

How has the price of INVEGA SUSTENNA 117 MG/0.75 ML changed over time?

Over the history we have for it, the NADAC for INVEGA SUSTENNA 117 MG/0.75 ML has risen 104.9%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for INVEGA SUSTENNA 117 MG/0.75 ML?

Since Nov 28, 2013, the NADAC for INVEGA SUSTENNA 117 MG/0.75 ML has ranged from a low of $1142.5583 (Nov 28, 2013) to a high of $2344.7659 (Jun 10, 2026), with a median of $1797.5591 per ML.

Are there cheaper alternatives to INVEGA SUSTENNA 117 MG/0.75 ML?

No other NADAC-published product currently shares the active ingredient and strength of INVEGA SUSTENNA 117 MG/0.75 ML in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures INVEGA SUSTENNA 117 MG/0.75 ML?

INVEGA SUSTENNA 117 MG/0.75 ML (NDC 50458056201) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.